Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

IZEA schedules Q1 2026 earnings call for May 12 to discuss financial results and outlook.

Company Fundamentals
05 May 2026
GlobeNewsWire
View Source
Neutral
pluang ai news

IZEA Worldwide, Inc., a leader in influencer marketing and creator economy solutions, announced its Q1 2026 earnings conference call will be held on May 12, 2026, at 5:00 p.m. EST. CEO Patrick Venetucci and CFO Peter Biere will review the company's financial performance and answer questions. This call follows IZEA's recent innovations, including the launch of its AI-powered marketing platform ZED and a strong profitability turnaround in early 2026. Investors can join via webcast or phone, with a replay available until May 19, 2026.

More News

Dycom reports record Q1 revenue growth of 56%, raises full-year outlook, and plans acquisition to boost data center services.

Dycom reports record Q1 revenue growth of 56%, raises full-year outlook, and plans acquisition to boost data center services.

Dycom Industries reported a record first quarter with contract revenues up 56.1% to $1.965 billion and adjusted net income nearly doubling to $134.3 million. The company raised its full-year fiscal 2027 revenue outlook to $7.38-$7.65 billion, driven ...

Company Fundamentals
Bullish
20 minutes ago
BrewDog launches UK-wide summer campaign with beer giveaways and football watch parties

BrewDog launches UK-wide summer campaign with beer giveaways and football watch parties

BrewDog, part of Tilray Brands, is rolling out a major summer campaign across the UK tied to the global football tournament. The campaign features a "Win a Year of Beer" contest with special cans hidden in over 2.8 million packs at major retailers, p...

Market News
Bullish
20 minutes ago
Autolus Therapeutics to present at two investor conferences in early June 2026

Autolus Therapeutics to present at two investor conferences in early June 2026

Autolus Therapeutics, a biopharmaceutical company specializing in next-generation T cell therapies, announced it will present at two upcoming investor conferences: William Blair’s Growth Stock Conference on June 2 and Jefferies Global Healthcare Conf...

Market News
Neutral
20 minutes ago
G-III Apparel Group declares quarterly dividend of $0.10 per share payable July 8, 2026.

G-III Apparel Group declares quarterly dividend of $0.10 per share payable July 8, 2026.

G-III Apparel Group announced a quarterly cash dividend of $0.10 per share, payable on July 8, 2026, to shareholders of record as of June 22, 2026. This dividend reflects the company's ongoing commitment to returning value to its investors. G-III is ...

Company Fundamentals
Neutral
20 minutes ago
Atea Pharma shows low drug interaction risk for new Hepatitis C treatment and promising Hepatitis E antiviral data.

Atea Pharma shows low drug interaction risk for new Hepatitis C treatment and promising Hepatitis E antiviral data.

Atea Pharmaceuticals announced Phase 1 results indicating their Hepatitis C treatment regimen, combining bemnifosbuvir and ruzasvir, has a low risk of drug-drug interactions with common medications like omeprazole and rosuvastatin. This supports easi...

Market News
Bullish
20 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App